PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15840771-2 2005 Prostaglandin E2 (PGE2) antagonizes vasopressin-induced P(f) of IMCD. Dinoprostone 0-16 arginine vasopressin Rattus norvegicus 36-47 18216147-1 2008 Prostaglandin E(2) may antagonize vasopressin-stimulated salt absorption in the thick ascending limb and water absorption in the collecting duct. Dinoprostone 0-18 arginine vasopressin Rattus norvegicus 34-45 15840771-2 2005 Prostaglandin E2 (PGE2) antagonizes vasopressin-induced P(f) of IMCD. Dinoprostone 18-22 arginine vasopressin Rattus norvegicus 36-47 14684611-5 2004 Chronic treatment of Brattleboro rats with vasopressin for 1 wk led to a decrease in urine volume and a moderate increase in medullary COX-1; in contrast, medullary COX-2 expression was almost undetectable in untreated rats but was dramatically up-regulated with vasopressin treatment and was accompanied by increased urinary prostaglandin E(2) excretion. Dinoprostone 326-344 arginine vasopressin Rattus norvegicus 43-54 10193786-0 1999 Cell-specific coupling of PGE2 to different transduction pathways in arginine vasopressin- and glucagon-sensitive segments of the rat renal tubule. Dinoprostone 26-30 arginine vasopressin Rattus norvegicus 78-89 10710543-0 2000 Prostaglandin E(2) interaction with AVP: effects on AQP2 phosphorylation and distribution. Dinoprostone 0-18 arginine vasopressin Rattus norvegicus 36-39 10710543-1 2000 Prostaglandin E(2) (PGE(2)) antagonizes the action of arginine vasopressin (AVP) on collecting duct water permeability. Dinoprostone 0-18 arginine vasopressin Rattus norvegicus 54-74 10710543-1 2000 Prostaglandin E(2) (PGE(2)) antagonizes the action of arginine vasopressin (AVP) on collecting duct water permeability. Dinoprostone 0-18 arginine vasopressin Rattus norvegicus 76-79 10710543-1 2000 Prostaglandin E(2) (PGE(2)) antagonizes the action of arginine vasopressin (AVP) on collecting duct water permeability. Dinoprostone 20-26 arginine vasopressin Rattus norvegicus 54-74 10710543-1 2000 Prostaglandin E(2) (PGE(2)) antagonizes the action of arginine vasopressin (AVP) on collecting duct water permeability. Dinoprostone 20-26 arginine vasopressin Rattus norvegicus 76-79 12829746-0 2003 The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho. Dinoprostone 4-20 arginine vasopressin Rattus norvegicus 54-65 10794664-8 2000 However, PGE(2) (10 nM) abolished the stimulatory effect of vasopressin. Dinoprostone 9-15 arginine vasopressin Rattus norvegicus 60-71 10638427-1 1999 The aim of this study was to pursue the roles of the catecholamine receptors in the anteroventral third ventricular region (AV3V), a cerebral site engaged in various stress responses, in prostaglandin (PG) E2-evoked vasopressin (AVP) release and cardiovascular action. Dinoprostone 187-208 arginine vasopressin Rattus norvegicus 229-232 10193786-4 1999 In the OMCD, 0.3 microM PGE2 and low concentrations of Ca2+ ionophores (10 nM ionomycin or 50 nM A23187) inhibited by about 50% a same pool of arginine vasopressin (AVP)-stimulated cyclic AMP content through a same process insensitive to Bordetella pertussis toxin (PTX). Dinoprostone 24-28 arginine vasopressin Rattus norvegicus 152-163 9917864-5 1998 The larger fevers may be due, in part, to a lack of AVP-induced antipyresis, as an AVP antagonist elevates PGE2 fever in male but not in female rats and dialysates of the ventral septal area show increased AVP levels only in male rats during defervescence. Dinoprostone 107-111 arginine vasopressin Rattus norvegicus 83-86 9917864-5 1998 The larger fevers may be due, in part, to a lack of AVP-induced antipyresis, as an AVP antagonist elevates PGE2 fever in male but not in female rats and dialysates of the ventral septal area show increased AVP levels only in male rats during defervescence. Dinoprostone 107-111 arginine vasopressin Rattus norvegicus 83-86 9176362-0 1997 Differential ventral septal vasopressin release is associated with sexual dimorphism in PGE2 fever. Dinoprostone 88-92 arginine vasopressin Rattus norvegicus 28-39 9575903-4 1998 The hormonal stimulation pattern of PGE2 and cAMP production by arginine vasopressin, angiotensin II, and dopamine in the isolated cells also argued against significant contamination by other cell types. Dinoprostone 36-40 arginine vasopressin Rattus norvegicus 73-84 9578155-4 1998 The production of PGE2 increased with AVP treatment, and the decline in methylated phospholipids paralleled the release of PGE2 in AVP-stimulated cells. Dinoprostone 18-22 arginine vasopressin Rattus norvegicus 38-41 9578155-4 1998 The production of PGE2 increased with AVP treatment, and the decline in methylated phospholipids paralleled the release of PGE2 in AVP-stimulated cells. Dinoprostone 123-127 arginine vasopressin Rattus norvegicus 131-134 9578155-5 1998 The inhibition of phospholipid methylation by treatment with adenosyl-S-isobutyl mercaptan (SIBA) resulted in a marked decrease in AVP-stimulated PGE2 production. Dinoprostone 146-150 arginine vasopressin Rattus norvegicus 131-134 9578155-8 1998 These findings indicate that AVP stimulates phospholipid methylation in cultured rat mesangial cells and phosphatidylcholine, synthesized by a transmethylation pathway, may be a source for PGE2 production. Dinoprostone 189-193 arginine vasopressin Rattus norvegicus 29-32 9176373-1 1997 In the medullary thick ascending limb (MTAL) of the rat kidney, prostaglandin E2 (PGE2) reverses inhibition of HCO3 absorption by arginine vasopressin (AVP). Dinoprostone 64-80 arginine vasopressin Rattus norvegicus 152-155 9176373-1 1997 In the medullary thick ascending limb (MTAL) of the rat kidney, prostaglandin E2 (PGE2) reverses inhibition of HCO3 absorption by arginine vasopressin (AVP). Dinoprostone 82-86 arginine vasopressin Rattus norvegicus 152-155 9176373-7 1997 In inner stripe tissue incubated with 10(10) M AVP, PGE2 10(6) M for 20 min) induced translocation of PKC-delta from the cytosolic fraction to the membrane fraction. Dinoprostone 52-56 arginine vasopressin Rattus norvegicus 47-50 9063712-3 1997 The injection of prostaglandin E2 into the anteroventral third ventricular region augmented plasma vasopressin and arterial pressure after 5 min and 15 min, without influencing plasma osmolality, sodium, potassium, or chloride. Dinoprostone 17-33 arginine vasopressin Rattus norvegicus 99-110 9176373-12 1997 These results demonstrate that 1) the MTAL expresses Ca(2+)-dependent (alpha, beta II) and Ca(2+)-independent (delta, epsilon, zeta) PKC isoforms; 2) PGE2 causes selective activation of PKC-delta, which likely mediates the action of PGE2 to reverse AVP inhibition of HCO-3 absorption; and 3) PGE2 activation of PKC-delta requires the presence of AVP, which may explain the fact that PGE2 influences HCO-3 transport only when AVP is present. Dinoprostone 150-154 arginine vasopressin Rattus norvegicus 249-252 9176373-12 1997 These results demonstrate that 1) the MTAL expresses Ca(2+)-dependent (alpha, beta II) and Ca(2+)-independent (delta, epsilon, zeta) PKC isoforms; 2) PGE2 causes selective activation of PKC-delta, which likely mediates the action of PGE2 to reverse AVP inhibition of HCO-3 absorption; and 3) PGE2 activation of PKC-delta requires the presence of AVP, which may explain the fact that PGE2 influences HCO-3 transport only when AVP is present. Dinoprostone 150-154 arginine vasopressin Rattus norvegicus 346-349 9176373-12 1997 These results demonstrate that 1) the MTAL expresses Ca(2+)-dependent (alpha, beta II) and Ca(2+)-independent (delta, epsilon, zeta) PKC isoforms; 2) PGE2 causes selective activation of PKC-delta, which likely mediates the action of PGE2 to reverse AVP inhibition of HCO-3 absorption; and 3) PGE2 activation of PKC-delta requires the presence of AVP, which may explain the fact that PGE2 influences HCO-3 transport only when AVP is present. Dinoprostone 150-154 arginine vasopressin Rattus norvegicus 346-349 7615808-4 1995 CRF cells do respond normally to forskolin or cholera toxin and the defect in AVP responsiveness is not prevented by treatment with pertussis toxin, by cyclooxygenase inhibition, or by inhibition or down-regulation of protein kinase C. In contrast to their lack of responsiveness to AVP, CRF cells respond normally to other agonists of adenylyl cyclase such as isoproterenol or prostaglandin E2. Dinoprostone 378-394 arginine vasopressin Rattus norvegicus 78-81 8764317-9 1996 We conclude that 1) PGE2 reverses AVP inhibition of HCO3- absorption by activation of PKC, 2) PKC likely increases JHCO3 by inhibiting AVP-stimulated cAMP production via a Gi-dependent mechanism, and 3) PKC activity has no influence on basal HCO3- absorption rate. Dinoprostone 20-24 arginine vasopressin Rattus norvegicus 34-37 8764317-9 1996 We conclude that 1) PGE2 reverses AVP inhibition of HCO3- absorption by activation of PKC, 2) PKC likely increases JHCO3 by inhibiting AVP-stimulated cAMP production via a Gi-dependent mechanism, and 3) PKC activity has no influence on basal HCO3- absorption rate. Dinoprostone 20-24 arginine vasopressin Rattus norvegicus 135-138 7650056-9 1995 Supramaximal concentrations of vasopressin, a strong activator of phospholipase C in hepatocytes, acted additively with PGE2 on the DNA synthesis. Dinoprostone 120-124 arginine vasopressin Rattus norvegicus 31-42 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 0-4 arginine vasopressin Rattus norvegicus 14-17 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 0-4 arginine vasopressin Rattus norvegicus 250-253 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 0-4 arginine vasopressin Rattus norvegicus 250-253 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 153-169 arginine vasopressin Rattus norvegicus 14-17 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 153-169 arginine vasopressin Rattus norvegicus 250-253 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 153-169 arginine vasopressin Rattus norvegicus 250-253 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 171-175 arginine vasopressin Rattus norvegicus 250-253 8764317-0 1996 PGE2 reverses AVP inhibition of HCO3- absorption in rat MTAL by activation of protein kinase C. In the medullary thick ascending limb (MTAL) of the rat, prostaglandin E2 (PGE2) reverses inhibition of HCO3- absorption (JHCO3) by arginine vasopressin (AVP) by inhibiting AVP-stimulated adenosine 3",5"-cyclic monophosphate (cAMP) production. Dinoprostone 171-175 arginine vasopressin Rattus norvegicus 250-253 8928831-6 1996 In the presence of AVP and hyperosmolality (75 mM NaCl added to perfusate and bath), PGE2 increased JHCO3 from 1.4 +/- 0.1 to 7.5 +/- 0.5 pmol.min-1.mm-1 (P < 0.005). Dinoprostone 85-89 arginine vasopressin Rattus norvegicus 19-22 8928831-7 1996 PGE2 also stimulated JHCO3 in the presence of AVP and hypertonic urea. Dinoprostone 0-4 arginine vasopressin Rattus norvegicus 46-49 8928831-10 1996 The stimulation of JHCO3 by PGE2 in the presence of AVP was blocked by pretreatment with pertusis toxin (PTX, 2 x 10(-11) or 10(-8) M). Dinoprostone 28-32 arginine vasopressin Rattus norvegicus 52-55 8928831-13 1996 PGE2 may act as a counterregulatory factor to maintain a stable rate of HCO3- absorption in the MTAL during antidiuresis when circulating AVP levels and medullary osmolality are elevated. Dinoprostone 0-4 arginine vasopressin Rattus norvegicus 138-141 1338082-6 1992 Vasopressin stimulated the synthesis of both PGE2 and PGI2. Dinoprostone 45-49 arginine vasopressin Rattus norvegicus 0-11 7894530-0 1994 Arginine vasopressin antagonism of oxytocin-stimulated PGE2 release from rabbit amnion cells and the activities of thioanalogs of oxytocin and arginine vasopressin. Dinoprostone 55-59 arginine vasopressin Rattus norvegicus 9-20 7840337-7 1995 Sex differences in basal and AVP-induced 6-ketoprostaglandin (6-keto-PG) F1 alpha and PGE2 output by HT and NTC vasculature were reciprocal to sex differences in the vasoconstriction responses to AVP. Dinoprostone 86-90 arginine vasopressin Rattus norvegicus 29-32 7857372-2 1994 We previously reported that pituitary adenylate cyclase activating polypeptide (PACAP), prostaglandin E2 (PGE2) and carbacyclin, a stable analog of prostacyclin, have suppressive effects on vasopressin-induced DNA synthesis of rat aortic smooth muscle cells through cAMP production (Murase et al., J. Dinoprostone 88-104 arginine vasopressin Rattus norvegicus 190-201 7857372-2 1994 We previously reported that pituitary adenylate cyclase activating polypeptide (PACAP), prostaglandin E2 (PGE2) and carbacyclin, a stable analog of prostacyclin, have suppressive effects on vasopressin-induced DNA synthesis of rat aortic smooth muscle cells through cAMP production (Murase et al., J. Dinoprostone 106-110 arginine vasopressin Rattus norvegicus 190-201 8385171-7 1993 The presence of receptors for Ang II and AVP was assessed by measurement of prostaglandin E2 by a radioimmunoassay following stimulation with vasoactive peptides and a receptor-binding assay for Ang II. Dinoprostone 76-92 arginine vasopressin Rattus norvegicus 41-44 1338082-14 1992 CONCLUSIONS: These results suggest that arginine vasopressin has a suppressive effect on DNA synthesis in rat aortic smooth muscle cells by inhibiting progression from the late G1 into the S phase of the cell cycle through the synthesis of PGE2 and PGI2, and that protein kinase C acts as an amplifier of this mechanism. Dinoprostone 240-244 arginine vasopressin Rattus norvegicus 49-60 2454589-4 1988 The in vitro data of the intact rat kidney showed that lithium stimulated arginine vasopressin (AVP)-induced PGE2 production and suggested that PGE2 suppressed cAMP synthesis in rat renal medulla. Dinoprostone 109-113 arginine vasopressin Rattus norvegicus 83-94 1630026-7 1992 The production of PGE2 increased with AVP treatment. Dinoprostone 18-22 arginine vasopressin Rattus norvegicus 38-41 2108083-2 1990 Basal and arginine vasopressin (AVP)-induced PGE2 production by interstitial cells from salt-resistant rats was fourfold to fivefold higher than corresponding values of those from the salt-sensitive rats. Dinoprostone 45-49 arginine vasopressin Rattus norvegicus 19-30 2312525-10 1990 It is concluded that the release of PGE2 and PGF2 alpha from the rat and human vas deferens is not correlated with contraction. Dinoprostone 36-40 arginine vasopressin Rattus norvegicus 79-82 2533261-5 1989 Increases in renal prostaglandin E2 (PGE2) synthesis were also associated with AVP infusion. Dinoprostone 19-35 arginine vasopressin Rattus norvegicus 79-82 2533261-5 1989 Increases in renal prostaglandin E2 (PGE2) synthesis were also associated with AVP infusion. Dinoprostone 37-41 arginine vasopressin Rattus norvegicus 79-82 3164726-5 1988 Vasopressin enhanced PGE2 synthesis by mechanisms independent of extracellular Ca2+ concentration. Dinoprostone 21-25 arginine vasopressin Rattus norvegicus 0-11 3164726-7 1988 When cytosolic free Ca2+ concentration ([Ca2+]f) was set at levels equal to those measured after stimulation with vasopressin in the intact cell, the PGE2 production by the Ca2+-clamped permeabilized cells was approximately one-half of that obtained in nonpermeabilized cells stimulated with vasopressin. Dinoprostone 150-154 arginine vasopressin Rattus norvegicus 114-125 3164726-7 1988 When cytosolic free Ca2+ concentration ([Ca2+]f) was set at levels equal to those measured after stimulation with vasopressin in the intact cell, the PGE2 production by the Ca2+-clamped permeabilized cells was approximately one-half of that obtained in nonpermeabilized cells stimulated with vasopressin. Dinoprostone 150-154 arginine vasopressin Rattus norvegicus 292-303 3164726-9 1988 When permeabilized cells were exposed to Ca2+ concentrations in the range of [Ca2+]f measured in cells treated with vasopressin the addition of PMA approximately doubled PGE2 production. Dinoprostone 170-174 arginine vasopressin Rattus norvegicus 116-127 3164726-12 1988 Thus, vasopressin-induced PGE2 production could be explained by a synergistic effect of protein kinase C activation together with an increase in [Ca2+]f. A synergistic action of Ca2+ and PMA on acylhydrolase activity could also be observed in nonpermeabilized cells where A23187 was used to increase [Ca2+]f. The effect of PMA was mimicked by another stimulant of protein kinase C, 1-oleoyl 2-acetylglycerol, albeit with lower potency. Dinoprostone 26-30 arginine vasopressin Rattus norvegicus 6-17 2312525-2 1990 The rat vas deferens releases both PGE2 and PGF2 alpha under basal conditions in vitro but the human vas deferens synthesizes prostaglandins only when arachidonic acid is supplied exogenously. Dinoprostone 35-39 arginine vasopressin Rattus norvegicus 8-11 2718697-1 1989 Brattleboro rats with hereditary diabetes insipidus make it possible to investigate effects of the urea concentration on the in vitro and in vivo production of prostaglandins E2 and F2 alpha (PGE2 and PGF2 alpha) by the renal papilla independently of any vasopressin effects. Dinoprostone 192-196 arginine vasopressin Rattus norvegicus 255-266 2740415-0 1989 Effects of prostaglandin E2 and D2 on the release of vasopressin and oxytocin. Dinoprostone 11-27 arginine vasopressin Rattus norvegicus 53-64 2454589-9 1988 It is postulated that lithium stimulates vasopressin release from the central nervous system and that elevated plasma vasopressin potentiates PGE2 production in the kidney synergistically with lithium. Dinoprostone 142-146 arginine vasopressin Rattus norvegicus 118-129 3124830-7 1988 EGF also markedly potentiated the stimulation of PGE2 production by vasopressin, which increases intracellular Ca2+ and activates protein kinase C in these cells. Dinoprostone 49-53 arginine vasopressin Rattus norvegicus 68-79 3462422-1 1986 Increased urinary prostaglandin E excretion (UPGE2V) and renal production of PGE2 have been implicated in the mediation of escape from inappropriate antidiuresis induced by vasopressin (AVP). Dinoprostone 46-50 arginine vasopressin Rattus norvegicus 173-184 3324719-1 1987 Cultured rat vascular smooth muscle cells from mesenteric artery produced prostaglandin (PG)E2, PGF2 alpha, PGI2 and thromboxane (TX)A2 in response to arachidonic acid, calcium ionophore A23187, vasopressin and angiotensin II. Dinoprostone 74-94 arginine vasopressin Rattus norvegicus 195-206 3465530-4 1986 Administration of deamino-8-D-arginine vasopressin was accompanied by a marked increase in PGE2 and PGF2 alpha excretion in both control and DEX-treated animals, but the response was significantly higher during DEX treatment. Dinoprostone 91-95 arginine vasopressin Rattus norvegicus 39-50 3020064-0 1986 Prostaglandin E2 synthesis in the inner medullary collecting duct of the rat: implications for vasopressin-dependent cyclic AMP formation. Dinoprostone 0-16 arginine vasopressin Rattus norvegicus 95-106 3018594-4 1986 The concentration-response curve of vasopressin was shifted to the right about 8-fold by PGE2 (1 mumol/l) without altering the maximum effect. Dinoprostone 89-93 arginine vasopressin Rattus norvegicus 36-47 2429831-3 1986 In contrast, the vasoactive peptides angiotensin II, vasopressin, and bradykinin stimulate PGI2 production, but not PGE2 production or triglyceride lipolysis, in these cells. Dinoprostone 116-120 arginine vasopressin Rattus norvegicus 53-64 3019160-3 1986 Arginine vasopressin (AVP) but not 1-deamino-8-D-arginine vasopressin (dDAVP) (10(-10)-10(-6) M), induced a dose-dependent increase in PGE2 synthesis, whereas AVP and dDAVP produced a similar dose-dependent increase in cAMP synthesis. Dinoprostone 135-139 arginine vasopressin Rattus norvegicus 0-20 3019160-3 1986 Arginine vasopressin (AVP) but not 1-deamino-8-D-arginine vasopressin (dDAVP) (10(-10)-10(-6) M), induced a dose-dependent increase in PGE2 synthesis, whereas AVP and dDAVP produced a similar dose-dependent increase in cAMP synthesis. Dinoprostone 135-139 arginine vasopressin Rattus norvegicus 9-20 2422957-0 1986 Osmolality, vasopressin-stimulated cAMP, and PGE2 synthesis in rat collecting tubule cells. Dinoprostone 45-49 arginine vasopressin Rattus norvegicus 12-23 2422957-9 1986 We conclude that conditions that prevail in vivo during antidiuresis, namely hypertonicity of the papillary interstitium, may augment vasopressin responsiveness through increments of collecting tubule cAMP and reductions of PGE2 which could, in concert, maximize water reabsorption in the collecting tubule. Dinoprostone 224-228 arginine vasopressin Rattus norvegicus 134-145 2995530-3 1985 Two chemically dissimilar inhibitors of calmodulin, namely trifluoperazine and N-(6-amino-hexyl)-5-chloro-1-naphthalenesulphonamide (W-7), attenuated the AVP-, PGE2- and forskolin-stimulated cellular production of cyclic AMP in a dose-related manner. Dinoprostone 160-164 arginine vasopressin Rattus norvegicus 154-157 3007904-0 1986 Functional compartmentalization of arginine-vasopressin-activated cyclic AMP in anterior pituitary gland: the presence of a compartment activated by prostaglandin E2. Dinoprostone 149-165 arginine vasopressin Rattus norvegicus 44-55 3706534-3 1986 Norepinephrine (NE) stimulated PGE2 (from 2,117 +/- 117 to 3,968 +/- 182 pg X mg protein-1 X 60 min-1, P less than 0.01) at a concentration of 10(-4)M and PGF2 alpha (from 2,748 +/- 285 to 8,535 +/- 495 pg X mg protein-1 X 60 min-1, P less than 0.01) at a concentration of 10(-5)M. However, neither angiotensin II (ANG II) nor arginine vasopressin (AVP) affected the release of PG and TXB2 at concentrations up to 10(-5)M. In the presence of 10(-5) M NE, ANG II enhanced the release of PGE2 (from 3,307 +/- 207 to 6,865 +/- 469 pg X mg protein-1 X 60 min-1., P less than 0.01) and PGF2 alpha (from 3,652 +/- 252 to 6,612 +/- 388 pg X mg protein-1 X 60 min-1, P less than 0.01) at a concentration of 10(-8)M, whereas AVP lacked any similar effect. Dinoprostone 31-35 arginine vasopressin Rattus norvegicus 336-347 3459194-5 1986 Vasopressin tannate treatment (0.5 U/day for 5 days) increased urinary PG excretion, and increased in vitro PGE2 synthesis in both inner and outer medullary slices of DI rats to levels that did not differ from vehicle-treated LE controls. Dinoprostone 108-112 arginine vasopressin Rattus norvegicus 0-11 3100918-6 1986 Neither bradykinin nor arginine vasopressin exhibit any further PG stimulation at 1 mM calcium; both bradykinin and arginine vasopressin increase PGE2 production significantly when calcium is increased to a supraphysiologic level. Dinoprostone 146-150 arginine vasopressin Rattus norvegicus 125-136 2995530-6 1985 Since forskolin directly activates adenylate cyclase at a site of the catalytic unit and the cellular action of AVP to activate adenylate cyclase is mediated through receptor-guanine nucleotide regulatory-catalytic units, the present study indicates calmodulin regulation of basal, AVP-, PGE2- and forskolin-activated adenylate cyclase in the papillary collecting tubule cells. Dinoprostone 288-292 arginine vasopressin Rattus norvegicus 112-115 3160802-0 1985 Inhibition by prostaglandin E2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro. Dinoprostone 14-30 arginine vasopressin Rattus norvegicus 49-60 4030047-4 1985 Administration of norepinephrine (1-10 nmol), arginine vasopressin (0.03-0.3 nmol), or angiotensin II (0.1-1 nmol) produced vasoconstriction and increased the output of 6-keto-prostaglandin F1 alpha and prostaglandin E2 in a dose-related manner in mesenteric vessels. Dinoprostone 203-219 arginine vasopressin Rattus norvegicus 55-66 3000838-6 1985 Since forskolin is recognized as activating adenylate cyclase at one step of the catalytic component and the cellular action of AVP to activate adenylate cyclase is mediated through receptor-catalytic component, the present study indicates calmodulin regulation of basal, AVP-, PGE2- and forskolin-activated adenylate cyclase in the papillary collecting tubule cells. Dinoprostone 278-282 arginine vasopressin Rattus norvegicus 128-131 3160802-3 1985 Prostaglandin (PG) E2 did not influence resting release of vasopressin but markedly inhibited (by about 50%) electrically induced release of vasopressin (least effective concentration: 300 nmol/l) as well as spontaneous secretion of beta-EI (least effective concentration: 100 nmol/l) in the presence of indomethacin (28 mumol/l). Dinoprostone 0-21 arginine vasopressin Rattus norvegicus 141-152 3160802-6 1985 As observed in the neurohypophysis, PGE2 inhibited the electrically induced release of vasopressin from the medial basal hypothalamus in vitro. Dinoprostone 36-40 arginine vasopressin Rattus norvegicus 87-98 3160802-7 1985 We conclude that prostaglandins (especially PGE2) can inhibit (1) the stimulated release of vasopressin when acting on vasopressin-containing nerve terminals of either neurosecretory system (neurohypophysis, median eminence region), and (2) the secretion of beta-EI and, as can be inferred, alpha-MSH, by a direct action on intermediate lobe cells. Dinoprostone 44-48 arginine vasopressin Rattus norvegicus 92-103 3160802-7 1985 We conclude that prostaglandins (especially PGE2) can inhibit (1) the stimulated release of vasopressin when acting on vasopressin-containing nerve terminals of either neurosecretory system (neurohypophysis, median eminence region), and (2) the secretion of beta-EI and, as can be inferred, alpha-MSH, by a direct action on intermediate lobe cells. Dinoprostone 44-48 arginine vasopressin Rattus norvegicus 119-130 6204854-0 1984 Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Dinoprostone 96-112 arginine vasopressin Rattus norvegicus 143-154 3922746-6 1985 Addition of PGE2 to incubated fragments of neural lobes of the rat pituitary stimulates secretion of both arginine vasopressin (AVP) and oxytocin in vitro. Dinoprostone 12-16 arginine vasopressin Rattus norvegicus 115-126 6439189-1 1984 [Arginine]vasopressin (AVP) stimulates maximal prostaglandin E2 production in cultured rat renal mesangial cells within 2 min. Dinoprostone 47-63 arginine vasopressin Rattus norvegicus 10-21 6439189-1 1984 [Arginine]vasopressin (AVP) stimulates maximal prostaglandin E2 production in cultured rat renal mesangial cells within 2 min. Dinoprostone 47-63 arginine vasopressin Rattus norvegicus 23-26 6094207-0 1984 Centrally administered PGE2 inhibits gastric secretion in the rat by releasing vasopressin. Dinoprostone 23-27 arginine vasopressin Rattus norvegicus 79-90 6094207-5 1984 administration of 3 micrograms of PGE2 increased the plasma level of vasopressin but had no effect on plasma beta-endorphin/beta-lipotropin. Dinoprostone 34-38 arginine vasopressin Rattus norvegicus 69-80 6094207-9 1984 The results indicate that the central antisecretory action of PGE2 is due to the release of vasopressin from the pituitary gland. Dinoprostone 62-66 arginine vasopressin Rattus norvegicus 92-103 6204854-9 1984 We conclude that PGE2 is formed locally subsequent to binding of the neurohormones and may act as a negative feedback-modulator of vasopressin"s and CRF-(1-41)"s activity in the anterior pituitary gland. Dinoprostone 17-21 arginine vasopressin Rattus norvegicus 131-142 6595999-5 1984 ANG II and vasopressin stimulate the synthesis of PGE2 in rat glomerular epithelial and mesangial cells maintained in cell culture. Dinoprostone 50-54 arginine vasopressin Rattus norvegicus 11-22 6088884-1 1984 Prostacyclin (PGI2) and prostaglandin E2 (PGE2) production by rat glomerular epithelial cells in culture were stimulated by arginine vasopressin (AVP) over a dose range of 10(-9) to 10(-6) M, but only if the cells were allowed to recover from trypsin treatment. Dinoprostone 24-40 arginine vasopressin Rattus norvegicus 133-144 6088884-1 1984 Prostacyclin (PGI2) and prostaglandin E2 (PGE2) production by rat glomerular epithelial cells in culture were stimulated by arginine vasopressin (AVP) over a dose range of 10(-9) to 10(-6) M, but only if the cells were allowed to recover from trypsin treatment. Dinoprostone 24-40 arginine vasopressin Rattus norvegicus 146-149 6088884-1 1984 Prostacyclin (PGI2) and prostaglandin E2 (PGE2) production by rat glomerular epithelial cells in culture were stimulated by arginine vasopressin (AVP) over a dose range of 10(-9) to 10(-6) M, but only if the cells were allowed to recover from trypsin treatment. Dinoprostone 42-46 arginine vasopressin Rattus norvegicus 133-144 6088884-1 1984 Prostacyclin (PGI2) and prostaglandin E2 (PGE2) production by rat glomerular epithelial cells in culture were stimulated by arginine vasopressin (AVP) over a dose range of 10(-9) to 10(-6) M, but only if the cells were allowed to recover from trypsin treatment. Dinoprostone 42-46 arginine vasopressin Rattus norvegicus 146-149 6193269-2 1983 Arginine vasopressin caused a marked antidiuretic response (urinary osmolality increased from 118 to 739 mosmol/l) which was accompanied by a significant increase in urinary prostaglandin excretion (prostaglandin E2 and F2 alpha excretion increased by 182 and 441%, respectively). Dinoprostone 199-215 arginine vasopressin Rattus norvegicus 9-20 6330512-9 1984 Such an effect of PGE2 may underlie, at least in part, in the inhibition by PGE2 of vasopressin-mediated urinary concentration. Dinoprostone 18-22 arginine vasopressin Rattus norvegicus 84-95 6330512-9 1984 Such an effect of PGE2 may underlie, at least in part, in the inhibition by PGE2 of vasopressin-mediated urinary concentration. Dinoprostone 76-80 arginine vasopressin Rattus norvegicus 84-95 6191577-0 1983 Effect of PGE2 on vasopressin-dependent cell cAMP in isolated single nephron segments. Dinoprostone 10-14 arginine vasopressin Rattus norvegicus 18-29 6285066-5 1982 Lower urinary excretion of prostaglandin E2 in experimental animals and a failure of cyclo-oxygenase inhibition with 10 mg/kg of indomethacin to improve dehydration urine osmolality suggested that prostaglandin E2 antagonism of vasopressin action did not contribute to the concentration defect. Dinoprostone 197-213 arginine vasopressin Rattus norvegicus 228-239 6261588-10 1981 On the other hand, PGE2 inhibited VP-stimulated cAMP levels by 50%. Dinoprostone 19-23 arginine vasopressin Rattus norvegicus 34-36 7078362-8 1982 It is suggested that the water-conserving effect of vasopressin 1 day after the dietary change was suppressed by the very high PGE2 production, resulting in normal renal water excretion. Dinoprostone 127-131 arginine vasopressin Rattus norvegicus 52-63 736121-4 1978 Therapy of homozygotes with vasopressin tannate in oil resulted in a prompt increase in the urinary excretion of prostaglandin E2 and prostaglandin F2alpha. Dinoprostone 113-129 arginine vasopressin Rattus norvegicus 28-39 7452479-0 1980 The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture. Dinoprostone 71-87 arginine vasopressin Rattus norvegicus 23-34 6455045-10 1981 HNS released AVP in dose related manner to the osmotic challenge of sodium or glucose, and AVP release was stimulated from HNS by prostaglandin E2, but not by dopamine. Dinoprostone 130-146 arginine vasopressin Rattus norvegicus 91-94 736121-5 1978 1-Desamino-D-arginine vasopressin, a nonpressor analogue of vasopressin, also enhanced the renal production of prostaglandin E2. Dinoprostone 111-127 arginine vasopressin Rattus norvegicus 22-33 736121-5 1978 1-Desamino-D-arginine vasopressin, a nonpressor analogue of vasopressin, also enhanced the renal production of prostaglandin E2. Dinoprostone 111-127 arginine vasopressin Rattus norvegicus 60-71 736121-6 1978 We conclude that vasopressin (antidiuretic hormone) stimulates renal production and excretion of prostaglandin E2 and prostaglandin F2alpha in vivo. Dinoprostone 97-113 arginine vasopressin Rattus norvegicus 17-28 816640-11 1976 In similar experiments, iv administration of vasopressin (100, 200, or 400 mU) induced a rise in plasma GH when given to the hypohysectomized-transplanted rats, but was ineffective in intact controls; the administration of prostaglandin E2 (5.0 and 50.0 mug) increased plasma GH in both experimental conditions. Dinoprostone 223-239 arginine vasopressin Rattus norvegicus 45-56 5529469-0 1970 A possible role of prostaglandin E2 in the regulation of vasopressin secretion in rats. Dinoprostone 19-35 arginine vasopressin Rattus norvegicus 57-68 28988972-0 2018 Arginine vasopressin antagonizes the effects of prostaglandin E2 on the spontaneous activity of warm-sensitive and temperature-insensitive neurons in the medial preoptic area in rats. Dinoprostone 48-64 arginine vasopressin Rattus norvegicus 9-20 28988972-5 2018 AVP attenuated the inhibitory effect of PGE2 on warm-sensitive neurons, and reversed the excitatory effect of PGE2 on low-slope temperature-insensitive neurons, demonstrating that AVP antagonized the effects of PGE2 on the spontaneous activity of these neurons. Dinoprostone 40-44 arginine vasopressin Rattus norvegicus 0-3 28988972-7 2018 We also demonstrated that AVP attenuated the PGE2-induced decrease in the prepotential"s rate of rise in warm-sensitive neurons and the PGE2-induced increase in that in low-slope temperature-insensitive neurons through the V1a receptor. Dinoprostone 45-49 arginine vasopressin Rattus norvegicus 26-29 28988972-7 2018 We also demonstrated that AVP attenuated the PGE2-induced decrease in the prepotential"s rate of rise in warm-sensitive neurons and the PGE2-induced increase in that in low-slope temperature-insensitive neurons through the V1a receptor. Dinoprostone 136-140 arginine vasopressin Rattus norvegicus 26-29 28988972-8 2018 Together, these data indicated that AVP antagonized the PGE2-induced change in the spontaneous activity of warm-sensitive and low-slope temperature-insensitive neurons in the MPO partly by reducing the PGE2-induced change in the prepotential of these neurons in a V1a receptor-dependent manner. Dinoprostone 56-60 arginine vasopressin Rattus norvegicus 36-39 28988972-8 2018 Together, these data indicated that AVP antagonized the PGE2-induced change in the spontaneous activity of warm-sensitive and low-slope temperature-insensitive neurons in the MPO partly by reducing the PGE2-induced change in the prepotential of these neurons in a V1a receptor-dependent manner. Dinoprostone 202-206 arginine vasopressin Rattus norvegicus 36-39